v3.26.1
CONSOLIDATED STATEMENTS OF CONDITION - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Assets      
Cash and due from banks $ 543,654 $ 467,874 $ 616,216
Federal funds sold and securities purchased under resale agreements 65 64 63
Interest-bearing deposits with banks 3,051,665 3,180,553 4,238,237
Available-for-sale securities, at fair value 7,244,282 6,236,263 4,220,305
Held-to-maturity securities, at amortized cost, net of allowance for credit losses of $257, $260 and $446 at March 31, 2026, December 31, 2025 and March 31, 2025, respectively ($2.7 billion, $2.8 billion and $2.9 billion fair value at March 31, 2026, December 31, 2025 and March 31, 2025, respectively) 3,270,207 3,343,905 3,564,490
Equity securities with readily determinable fair value 63,786 63,770 270,442
Federal Home Loan Bank and Federal Reserve Bank stock 292,044 291,881 281,893
Mortgage loans held-for-sale, at fair value 383,405 340,745 316,804
Loans, net of unearned income 54,071,292 53,105,101 48,708,390
Allowance for loan losses (471,334) (460,205) (447,941)
Premises, software and equipment, net 777,603 781,611 776,679
Lease investments, net 362,766 360,646 280,472
Accrued interest receivable and other assets 1,596,617 1,617,682 1,598,255
Receivable on unsettled securities sales 0 835,275 463,023
Goodwill 797,658 797,960 796,932
Other acquisition-related intangible assets 93,040 97,999 116,072
Total assets 72,157,433 71,142,046 65,870,066
Deposits:      
Non-interest-bearing 12,112,891 11,423,701 11,201,859
Interest-bearing 46,801,491 46,293,490 42,368,179
Total deposits 58,914,382 57,717,191 53,570,038
Federal Home Loan Bank advances 3,451,309 3,451,309 3,151,309
Other borrowings 340,647 477,966 529,269
Subordinated notes 298,717 298,636 298,360
Junior subordinated debentures 253,566 253,566 253,566
Accrued interest payable and other liabilities 1,520,712 1,684,663 1,466,987
Total liabilities 64,779,333 63,883,331 59,269,529
Shareholders’ Equity:      
Common stock, no par value; $1.00 stated value; 100,000,000 shares authorized at March 31, 2026, December 31, 2025 and March 31, 2025; 67,563,372 shares issued at March 31, 2026, 67,062,182 shares issued at December 31, 2025 and 67,006,594 shares issued at March 31, 2025 67,563 67,062 67,007
Surplus 2,546,754 2,534,024 2,494,347
Treasury stock, at cost, $126,072 shares at March 31, 2026, 87,269 shares at December 31, 2025, and 87,269 shares at March 31, 2025 (13,970) (9,156) (9,156)
Retained earnings 4,719,561 4,537,539 4,045,854
Accumulated other comprehensive loss (366,808) (295,754) (410,015)
Total shareholders’ equity 7,378,100 7,258,715 6,600,537
Total liabilities and shareholders’ equity 72,157,433 71,142,046 65,870,066
Series D - $25 liquidation value; no shares issued and outstanding at March 31, 2026 and December 31, 2025 and 5,000,000 shares issued and outstanding at March 31, 2025      
Shareholders’ Equity:      
Preferred stock, no par value; 20,000,000 shares authorized: 0 0 125,000
Series E - $25,000 liquidation value; no shares issued and outstanding at March 31, 2026 and December 31, 2025 and 11,500 shares issued and outstanding at March 31, 2025      
Shareholders’ Equity:      
Preferred stock, no par value; 20,000,000 shares authorized: 0 0 287,500
Series F - $25,000 liquidation value; 17,000 shares issued and outstanding at March 31, 2026 and December 31, 2025 and no shares issued and outstanding at March 31, 2025      
Shareholders’ Equity:      
Preferred stock, no par value; 20,000,000 shares authorized: 425,000 425,000 0
Loans      
Assets      
Loans, net of unearned income 54,071,292 53,105,101 48,708,390
Allowance for loan losses (390,651) (379,283) (378,207)
Net loans $ 53,680,641 $ 52,725,818 $ 48,330,183